Personensuche
X
?
1
Supplementary Table 12 from A Randomized Phase III Study of..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942947.v1. , 2024
doi:10.1158/2767-9764.24942947.v1. , 2024
?
2
Supplementary Table 7 from A Randomized Phase III Study of ..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942920.v1. , 2024
doi:10.1158/2767-9764.24942920.v1. , 2024
?
3
Supplementary Table 11 from A Randomized Phase III Study of..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942950.v1. , 2024
doi:10.1158/2767-9764.24942950.v1. , 2024
?
5
Supplementary Figure 3 from A Randomized Phase III Study of..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942971.v1. , 2024
doi:10.1158/2767-9764.24942971.v1. , 2024
?
6
Supplementary Figure 6 from A Randomized Phase III Study of..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942962.v1. , 2024
doi:10.1158/2767-9764.24942962.v1. , 2024
?
7
Supplementary Figure 7 from A Randomized Phase III Study of..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942959.v1. , 2024
doi:10.1158/2767-9764.24942959.v1. , 2024
?
8
Supplementary Table 5 from A Randomized Phase III Study of ..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942926.v1. , 2024
doi:10.1158/2767-9764.24942926.v1. , 2024
?
9
Supplementary Table 15 from A Randomized Phase III Study of..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942938.v1. , 2024
doi:10.1158/2767-9764.24942938.v1. , 2024
?
10
Supplementary Figure 2 from A Randomized Phase III Study of..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942974.v1. , 2024
doi:10.1158/2767-9764.24942974.v1. , 2024
?
11
Supplementary Table 2 from A Randomized Phase III Study of ..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942935.v1. , 2024
doi:10.1158/2767-9764.24942935.v1. , 2024
?
12
FIGURE 1 from A Randomized Phase III Study of Arfolitixorin..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942983.v1. , 2024
doi:10.1158/2767-9764.24942983.v1. , 2024
?
13
Supplementary Table 9 from A Randomized Phase III Study of ..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942914.v1. , 2024
doi:10.1158/2767-9764.24942914.v1. , 2024
?
14
Supplementary Figure 5 from A Randomized Phase III Study of..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942965.v1. , 2024
doi:10.1158/2767-9764.24942965.v1. , 2024
?
15
Supplementary Table 4 from A Randomized Phase III Study of ..:
Josep Tabernero ; Takayuki Yoshino ; Sebastian Stintzing...
doi:10.1158/2767-9764.24942929.v1. , 2024
doi:10.1158/2767-9764.24942929.v1. , 2024